FindTrial
Sign In

Homeopathic medicine for prevention of dengue

Prophylactic effects of the homoeopathic medicine Eupatorium perfoliatum 30CH during the dengue outbreak in Kolkata: A comparative cohort study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/07/090258
Enrollment
1614
Registered
2025-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Nil: Nil Intervention2: Eupatorium perfoliatum 30CH plus standard information education communication guidelines for prevention of dengue fever: This group will receive Eupatorium perfo

Sponsors

Department of Science and Technology, Govt of West Bengal
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Healthy individuals of either sex or transgender b) Aged 1 year or above c) Providing with written informed assent and/or consent voluntarily

Exclusion criteria

Exclusion criteria: a) Persons having symptoms of dengue-like illness or fever in the last 7 days b) Individuals taking other preventive medicines for dengue c) Individuals with self-reported immunocompromised states d) Malignancies and other life-threatening or end-stage diseases e) Pregnant, puerperal, and lactating women f) Substance abuse and/or dependence g) Simultaneous participation in any clinical trial

Design outcomes

Primary

MeasureTime frame
Group differences in the occurrence of confirmed dengue fever (DF) cases.Timepoint: Baseline and 5 months of the current year; to be repeated again for next two years—

Secondary

MeasureTime frame
Group differences in the occurrence of probable dengue fever cases & hospitalizationTimepoint: Baseline & 5 months of the current year; to be repeated again for next two years—

Countries

India

Contacts

Public ContactAmitava Paul

D. N. De Homoeopathic Medical College and Hospital

drsubhranilsaha@hotmail.com9836187425

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026